Cargando…
Prolonged ICU Stay in Severe and Critically-Ill COVID-19 Patients Who Received Convalescent Plasma Therapy
BACKGROUND: Convalescent plasma administration in severe and critically-ill COVID-19 patients have been proven to not provide improvement in patients' outcome, yet it is still widely used in countries with limited resources due to its high availability and safety. This study aims to investigate...
Autores principales: | Semedi, Bambang Pujo, Ramadhania, Nadya Noor, Tambunan, Betty Agustina, Bintoro, Siprianus Ugroseno Yudho, Soedarsono, Soedarsono, Prakoeswa, Cita Rosita Sigit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473920/ https://www.ncbi.nlm.nih.gov/pubmed/36118915 http://dx.doi.org/10.1155/2022/1594342 |
Ejemplares similares
-
Immunomodulation Effect of Convalescent Plasma Therapy in Severe – Critical COVID-19 Patients
por: Fitriah, Munawaroh, et al.
Publicado: (2023) -
CD4+ AND CD8+ T-CELLS EXPRESSING INTERFERON GAMMA IN ACTIVE PULMONARY TUBERCULOSIS PATIENTS
por: Tambunan, Betty Agustina, et al.
Publicado: (2018) -
How to prioritize treatment in dual malignancy: A case report of patient with non-Hodgkin lymphoma and breast cancer
por: Chomariyati, Alvi, et al.
Publicado: (2022) -
Hematologic and coagulopathy parameter as a survival predictor among moderate to severe COVID-19 patients in non- ICU ward: a single-center study at the main referral hospital in Surabaya, East Java, Indonesia
por: Bintoro, Siprianus Ugroseno Yudho, et al.
Publicado: (2021) -
Case Report: Priapism as The Clinical Presenting Feature of Chronic Myeloid Leukemia: Case Report and 20-Year Literature Review
por: Bintoro, Siprianus Ugroseno Yudho, et al.
Publicado: (2022)